Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peri-strut low-intensity area assessed by midterm follow-up optical coherence tomography may predict target lesion revascularisation after everolimus-eluting stent implantation.
Kuroda K, Otake H, Shinke T, Toba T, Kuroda M, Takahashi H, Terashita D, Uzu K, Kashiwagi D, Nagasawa Y, Nagano Y, Hirata KI. Kuroda K, et al. Among authors: nagano y. EuroIntervention. 2019 Apr 20;14(17):1751-1759. doi: 10.4244/EIJ-D-17-01134. EuroIntervention. 2019. PMID: 29957594 Free article.
Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin.
Otake H, Sugizaki Y, Toba T, Nagano Y, Tsukiyama Y, Yanaka KI, Yamamoto H, Nagasawa A, Onishi H, Takeshige R, Nakano S, Matsuoka Y, Tanimura K, Kawamori H, Shinke T, Hirata KI. Otake H, et al. Among authors: nagano y. J Cardiol. 2019 Mar;73(3):228-232. doi: 10.1016/j.jjcc.2018.11.012. Epub 2018 Dec 19. J Cardiol. 2019. PMID: 30579806 Free article.
Impaired Cholesterol-Uptake Capacity of HDL Might Promote Target-Lesion Revascularization by Inducing Neoatherosclerosis After Stent Implantation.
Nagano Y, Otake H, Toba T, Kuroda K, Shinkura Y, Tahara N, Tsukiyama Y, Yanaka K, Yamamoto H, Nagasawa A, Onishi H, Sugizaki Y, Takeshige R, Harada A, Murakami K, Kiriyama M, Oshita T, Irino Y, Kawamori H, Ishida T, Toh R, Shinke T, Hirata KI. Nagano Y, et al. J Am Heart Assoc. 2019 May 7;8(9):e011975. doi: 10.1161/JAHA.119.011975. J Am Heart Assoc. 2019. PMID: 30995875 Free PMC article.
The impact of serum trans fatty acids concentration on plaque vulnerability in patients with coronary artery disease: Assessment via optical coherence tomography.
Nagasawa Y, Shinke T, Toh R, Ishida T, Otake H, Takaya T, Sugiyama D, Toba T, Kuroda M, Takahashi H, Terashita D, Tahara N, Shinkura Y, Uzu K, Kashiwagi D, Kuroda K, Nagano Y, Yamamoto H, Yanaka K, Tsukiyama Y, Hirata KI. Nagasawa Y, et al. Among authors: nagano y. Atherosclerosis. 2017 Oct;265:312-317. doi: 10.1016/j.atherosclerosis.2017.06.922. Epub 2017 Jun 28. Atherosclerosis. 2017. PMID: 28697847 Free article.
Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients.
Yamamoto H, Yoshida N, Shinke T, Otake H, Kuroda M, Sakaguchi K, Hirota Y, Toba T, Takahashi H, Terashita D, Uzu K, Tahara N, Shinkura Y, Kuroda K, Nagasawa Y, Nagano Y, Tsukiyama Y, Yanaka KI, Emoto T, Sasaki N, Yamashita T, Ogawa W, Hirata KI. Yamamoto H, et al. Among authors: nagano y. Atherosclerosis. 2018 Feb;269:245-251. doi: 10.1016/j.atherosclerosis.2018.01.010. Epub 2018 Jan 17. Atherosclerosis. 2018. PMID: 29407600
Impact of dual antiplatelet therapy with adjusted-dose prasugrel on mid-term vascular response in patients undergoing elective percutaneous coronary intervention with everolimus-eluting stents.
Toba T, Shinke T, Otake H, Sugizaki Y, Takeshige R, Onishi H, Nagasawa A, Tsukiyama Y, Yanaka K, Nagano Y, Yamamoto H, Kawamori H, Matsuura A, Ishihara T, Matsumoto D, Igarashi N, Hayashi T, Yasaka Y, Kadotani M, Fujii T, Shite J, Okada M, Sakakibara T, Hirata KI. Toba T, et al. Among authors: nagano y. Heart Vessels. 2019 Jun;34(6):936-947. doi: 10.1007/s00380-018-1322-2. Epub 2019 Jan 1. Heart Vessels. 2019. PMID: 30599059
Association of cholesterol uptake capacity, a novel indicator for HDL functionality, and coronary plaque properties: An optical coherence tomography-based observational study.
Oshita T, Toh R, Nagano Y, Kuroda K, Nagasawa Y, Harada A, Murakami K, Kiriyama M, Yoshikawa K, Miwa K, Kubo T, Iino T, Nagao M, Irino Y, Hara T, Shinohara M, Otake H, Shinke T, Nakajima K, Ishida T, Hirata KI. Oshita T, et al. Among authors: nagano y. Clin Chim Acta. 2020 Apr;503:136-144. doi: 10.1016/j.cca.2020.01.001. Epub 2020 Jan 21. Clin Chim Acta. 2020. PMID: 31972150
Progression from normal vessel wall to atherosclerotic plaque: lessons from an optical coherence tomography study with follow-up of over 5 years.
Takeshige R, Otake H, Kawamori H, Toba T, Nagano Y, Tsukiyama Y, Yanaka KI, Yamamoto H, Nagasawa A, Onishi H, Sugizaki Y, Nakano S, Matsuoka Y, Tanimura K, Hirata KI. Takeshige R, et al. Among authors: nagano y. Heart Vessels. 2022 Jan;37(1):1-11. doi: 10.1007/s00380-021-01889-w. Epub 2021 Aug 2. Heart Vessels. 2022. PMID: 34338851
Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery disease.
Yamamoto H, Yoshida N, Shinke T, Otake H, Kuroda M, Sakaguchi K, Hirota Y, Toba T, Takahashi H, Terashita D, Uzu K, Tahara N, Shinkura Y, Kuroda K, Nagasawa Y, Nagano Y, Tsukiyama Y, Yanaka KI, Emoto T, Sasaki N, Yamashita T, Ogawa W, Hirata KI. Yamamoto H, et al. Among authors: nagano y. Data Brief. 2018 Mar 10;18:172-175. doi: 10.1016/j.dib.2018.03.022. eCollection 2018 Jun. Data Brief. 2018. PMID: 29900190 Free PMC article.
737 results